CXCL16 and myeloid sarcoma: In this longitudinal study serum levels of CXCL16, OPG and MMP-9 reflect MRI activity in RRMS, suggesting that these markers, in particular CXCL16 which also may predict disease activity, could be potential markers of disease activity in MS.